SWK Holdings Corporation is a finance and investment firm primarily focused on acquiring and managing portfolios in the life sciences sector, specifically designed to achieve attractive risk-adjusted returns through innovative financial solutions for transformative therapies. The company enhances its strategic initiatives by issuing senior notes, including the notable 9.00% Senior Notes due 2027, which serves to capitalize on emerging growth opportunities in the healthcare market. With a strong investment strategy and in-depth industry expertise, SWK Holdings is positioned to deliver significant value to investors while navigating the complexities of a rapidly evolving landscape.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Volatility is currently contracting